ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION17 JULY 2024 at 8.30 EEST Inside information: Phase III ARANOTE trial of darolutamide in combination with androgen...
Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION1 JULY 2024 at 15:15 EEST Inside information: Orion upgrades full-year outlook for 2024 Orion Corporation upgrades the...
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION1 JULY 2024 at 15:15 EEST Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive...
ORION CORPORATION PRESS RELEASE 03 June 2024 at 09.30 EEST Orion is developing the Finnish life science industry in a unique collaboration project Orion is participating in a project led...
ORION CORPORATION STOCK EXCHANGE RELEASE “ CHANGES BOARD / MANAGEMENT / AUDITORS7 May 2024 at 08.30 EEST Orion Corporation: Change in Orion Group Executive Management Board as of 31 May...
ORION CORPORATION nMANAGERS’ TRANSACTIONS n6 MAY 2024 at 12.00 EEST nnnOrion Corporation: Managers’ transactions – Karen Lykke Sørensen nnOrion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. nnOrion Oyj - Managers' Transactions
ORION CORPORATION nMANAGERS’ TRANSACTIONS n6 MAY 2024 at 12.00 EEST nnnOrion Corporation: Managers’ transactions – Hilpi Rautelin nnOrion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. nnOrion Oyj - Managers' Transactions
ORION CORPORATION nMANAGERS’ TRANSACTIONS n6 MAY 2024 at 12.00 EEST nnnOrion Corporation: Managers’ transactions – Maziar Mike Doustdar nnOrion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. nnOrion Oyj - Managers' Transactions
ORION CORPORATION nMANAGERS’ TRANSACTIONS n6 MAY 2024 at 12.00 EEST nnnOrion Corporation: Managers’ transactions – Henrik Stenqvist nnOrion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. nnOrion Oyj - Managers' Transactions